Axcelius I/II
Axcelius I/II is a biopharmaceutical company-creation vehicle backed by Canaan Partners, formed to found and incubate drug-development companies pursuing treatments for cancer, rare diseases, and neurodegenerative disorders. It is led by managing partner Dennis Podlesak and sponsored at Canaan by general partner Brent Ahrens, and operates from San Francisco, California, with an associated holding entity registered in Connecticut at Canaan's Westport office. Rather than operating as a product company, Axcelius assembles management teams and capital around licensed therapeutic assets and spins them out as standalone biopharma companies; Transposon Therapeutics, developing therapies for ALS and Alzheimer's disease, is its best-documented creation. As of this enrichment pass the vehicle remains in stealth mode with no public developer surface -- no product website beyond a holding page, no documentation, developer portal, SDKs, GitHub organization, or API of any kind.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles Axcelius I/II the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Axcelius I/II scores 7.7/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
How we profile Axcelius I/II
Each block below is one kind of artifact we hold for Axcelius I/II. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Axcelius I/II — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Access & Security 1
Authentication, authorization, and security posture
Company 2
The organization behind the API
← All providers · Data indexed from github.com/api-evangelist/axcelius-i-ii · machine-readable index on apis.io